Neurotherapeutics in the Era of Translational Medicine focuses on the remarkable progress made in treating neurologic disorders which heretofore have been considered incurable. The book represents a celebration of this unique epoch in America that dates from the 1980’s, when it became possible to clone genes, and perhaps more importantly, with the sequencing of the entire human genome. Chapters include translational research in potential therapies for Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy, Huntington’s disease, Multiple Sclerosis, Parkinson’s Disease Myotonic Dystrophy, and Glioblastoma. The book also discusses general concerns of clinical trials, like trial designs and ethical issues. Neuroscientists, pharmacologists, and clinicians, especially neurologists and neurosurgeons will find this book useful.
Neurotherapeutics in the Era of Translational Medicine, 2020 Publication Date: November 29, 2020